Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-α production in mice

Gastroenterology

Volumn 121, Issue 6, 2001, Pages 1372-1379

  Hove, Tessa Ten ^a   Corbaz, Anne ^a   Amitai, Hagit ^b   Aloni, Shuki ^b   Belzer, Ilana ^b,c   Graber, Pierre ^a   Drillenburg, Paul ^a   Van Deventer, Sander J H ^a   Chvatchko, Yolande ^a   De Velde, Anje A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^c InterPharm Laboratories   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; RECOMBINANT HUMAN INTERLEUKIN 18 BINDING PROTEIN; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTOPATHOLOGY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TH1 CELL; ULCER; WEIGHT REDUCTION;

EID: 0035210979     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.29579     Document Type: Article

References (34)

1. Experimental models of inflammatory bowel disease
2. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease
3. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)
4. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
5. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
6. Bioactive IL-18 expression is up-regulated in Crohn's disease
7. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production
8. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers
9. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
10. Tumour necrosis factor and Crohn's disease
11. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease
12. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
13. Cloning of a new cytokine that induces IFN-gamma production by T cells
14. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production
15. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme
16. Purification and characterization of the human interleukin-18 receptor
17. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling
18. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1
19. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
20. Interleukin-18: Biological properties and clinical implications
21. Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures
22. Interleukin-18 activates NF-kappaB in murine T helper type 1 cells
23. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
24. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
25. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice
26. Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice
27. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses
28. IL-18 is a primary mediator of inflammation associated with DSS-induced colitis: Blocking IL-18 prevents intestinal damage (abstr 3739)
29. Interleukin-18 (IFNγ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells
30. IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12
31. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
32. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis
33. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
34. Infliximab for the treatment of fistulas in patients with Crohn's disease